South Korea · Delayed Price · Currency is KRW OSTEONIC Statistics
Total Valuation
OSTEONIC has a market cap or net worth of KRW 136.82 billion. The enterprise value is 137.18 billion.
| Market Cap | 136.82B |
| Enterprise Value | 137.18B |
Important Dates
The next estimated earnings date is Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OSTEONIC has 20.06 million shares outstanding. The number of shares has increased by 2.75% in one year.
| Current Share Class | 20.06M |
| Shares Outstanding | 20.06M |
| Shares Change (YoY) | +2.75% |
| Shares Change (QoQ) | +109.21% |
| Owned by Insiders (%) | 20.17% |
| Owned by Institutions (%) | 6.62% |
| Float | 16.00M |
Valuation Ratios
The trailing PE ratio is 18.53 and the forward PE ratio is 11.90.
| PE Ratio | 18.53 |
| Forward PE | 11.90 |
| PS Ratio | 3.01 |
| PB Ratio | 2.02 |
| P/TBV Ratio | 2.10 |
| P/FCF Ratio | 422.83 |
| P/OCF Ratio | 15.18 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.91, with an EV/FCF ratio of 423.94.
| EV / Earnings | 18.29 |
| EV / Sales | 3.02 |
| EV / EBITDA | 13.91 |
| EV / EBIT | 22.25 |
| EV / FCF | 423.94 |
Financial Position
The company has a current ratio of 2.96, with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.96 |
| Quick Ratio | 1.94 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 2.21 |
| Debt / FCF | 67.30 |
| Interest Coverage | 5.30 |
Financial Efficiency
Return on equity (ROE) is 11.82% and return on invested capital (ROIC) is 8.07%.
| Return on Equity (ROE) | 11.82% |
| Return on Assets (ROA) | 4.05% |
| Return on Invested Capital (ROIC) | 8.07% |
| Return on Capital Employed (ROCE) | 7.65% |
| Weighted Average Cost of Capital (WACC) | 8.39% |
| Revenue Per Employee | 236.42M |
| Profits Per Employee | 39.06M |
| Employee Count | 192 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.29 |
Taxes
In the past 12 months, OSTEONIC has paid 928.09 million in taxes.
| Income Tax | 928.09M |
| Effective Tax Rate | 11.01% |
Stock Price Statistics
The stock price has decreased by -5.06% in the last 52 weeks. The beta is 0.86, so OSTEONIC's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -5.06% |
| 50-Day Moving Average | 6,571.40 |
| 200-Day Moving Average | 6,727.55 |
| Relative Strength Index (RSI) | 55.29 |
| Average Volume (20 Days) | 98,676 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSTEONIC had revenue of KRW 45.39 billion and earned 7.50 billion in profits. Earnings per share was 368.00.
| Revenue | 45.39B |
| Gross Profit | 21.98B |
| Operating Income | 6.16B |
| Pretax Income | 8.43B |
| Net Income | 7.50B |
| EBITDA | 9.86B |
| EBIT | 6.16B |
| Earnings Per Share (EPS) | 368.00 |
Balance Sheet
The company has 21.54 billion in cash and 21.78 billion in debt, with a net cash position of -240.82 million or -12.00 per share.
| Cash & Cash Equivalents | 21.54B |
| Total Debt | 21.78B |
| Net Cash | -240.82M |
| Net Cash Per Share | -12.00 |
| Equity (Book Value) | 67.58B |
| Book Value Per Share | 3,362.65 |
| Working Capital | 38.90B |
Cash Flow
In the last 12 months, operating cash flow was 9.02 billion and capital expenditures -8.69 billion, giving a free cash flow of 323.57 million.
| Operating Cash Flow | 9.02B |
| Capital Expenditures | -8.69B |
| Depreciation & Amortization | 3.70B |
| Net Borrowing | 1.65B |
| Free Cash Flow | 323.57M |
| FCF Per Share | 16.13 |
Margins
Gross margin is 48.42%, with operating and profit margins of 13.58% and 16.52%.
| Gross Margin | 48.42% |
| Operating Margin | 13.58% |
| Pretax Margin | 18.56% |
| Profit Margin | 16.52% |
| EBITDA Margin | 21.72% |
| EBIT Margin | 13.58% |
| FCF Margin | 0.71% |
Dividends & Yields
OSTEONIC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.75% |
| Shareholder Yield | -2.75% |
| Earnings Yield | 5.48% |
| FCF Yield | 0.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 24, 2020. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 24, 2020 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
OSTEONIC has an Altman Z-Score of 3.65 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.65 |
| Piotroski F-Score | 6 |